Ranbaxy plans to relaunch skincare brand in U.S. - Economic Times
GSPC consortium in talks to buy BG stake in Gujarat Gas - Business Standard
… expired , and since November 30, 2011 there have been generics available from Watson Pharmaceuticals ( WPI ) and Ranbaxy Laboratories , with more certainly to come. Sales of Lipitor peaked at 12.8 billion in 2008. Sales were still over $10 …
* North America sales more than double to 20.9 bln rupees
* To launch the drug in other Asia countries, Africa, South America
NEW DELHI, April 25 (Reuters) - Ranbaxy Laboratories , India's top drugmaker by sales, launched in India malaria treatment drug Synriam, it said in an audio visual presentation on Wednesday.
… drug Lipitor. This is significant considering the cholesterol drug has been the best selling drug in the world. Ranbaxy Laboratories out of India will resume exporting drugs to the U.S. and Europe after a ban in 2008 when the US FDA found it …
MUMBAI (Reuters) - Ranbaxy Laboratories Ltd has started exports of a copycat version of blockbuster cholesterol drug Lipitor from a new facility in India that has been approved by the U.S. Food and Drug Administration.
* Big sales needed to make copycat version cost effective-analyst
… financials as generics selling for roughly 1/3 Lipitor's price immediately started hitting market by India's Ranbaxy Laboratories Ltd . ( RBXZF.PK ) and by Pfizer's partner, Watson Pharmaceuticals ( WPI ). As a result of the competition …